CNSP - CNS Pharmaceuticals Inc Stock Price, Fair Value and News

$0.110.00 (0.00%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CNSP Price Action

Last 7 days

10%

Last 30 days

-8.3%

Last 90 days

-21.4%

Trailing 12 Months

-90.6%

CNSP RSI Chart

CNSP Valuation

Market Cap

6.3M

Price/Earnings (Trailing)

-0.37

Price/Sales (Trailing)

249.16

Price/Free Cashflow

-0.49

CNSP Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CNSP Fundamentals

CNSP Revenue

Revenue (TTM)

27.7K

Rev. Growth (Qtr)

-3.87%

CNSP Earnings

Earnings (TTM)

-17.1M

Earnings Growth (Yr)

-23.95%

Earnings Growth (Qtr)

-121.51%

CNSP Profitability

Return on Equity

-508.8%

Return on Assets

-230.21%

Free Cashflow Yield

-205.59%

CNSP Investor Care

Shares Dilution (1Y)

54663.87%

Diluted EPS (TTM)

-58.48

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	27.7K

Get all data in R, Python etc through our Historical Stock Data APIs

About CNS Pharmaceuticals Inc

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas.

CEO	Mr. John Michael Climaco Esq., J.D.
WEBSITE	cnspharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	3

CNS Pharmaceuticals Inc Frequently Asked Questions

What is the ticker symbol for CNS Pharmaceuticals Inc? What does CNSP stand for in stocks?

CNSP is the stock ticker symbol of CNS Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CNS Pharmaceuticals Inc (CNSP)?

As of Fri Dec 20 2024, market cap of CNS Pharmaceuticals Inc is 6.32 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CNSP stock?

You can check CNSP's fair value in chart for subscribers.

Is CNS Pharmaceuticals Inc a good stock to buy?

The fair value guage provides a quick view whether CNSP is over valued or under valued. Whether CNS Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact CNS Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CNSP.

What is CNS Pharmaceuticals Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, CNSP's PE ratio (Price to Earnings) is -0.37 and Price to Sales (PS) ratio is 249.16. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CNSP PE ratio will change depending on the future growth rate expectations of investors.